
    
      3 groups.

      Group (C) / (I):20 patient (control group) :

      Patients will receive 20 ml 0.25% levobupivacaine into the interfascial plane below erector
      spinae muscle at level of T5.

      Group (D)/ (II) :20 patient (Dexmetonidine group) :

      Patient will receive 20ml 0.25% levobupivacaineas above + 1Î¼/kg dexmedetomidine.

      Group (M) / (III) : 20 patient (magnesium slphate group) :

      Patient will receive 20ml 0.25% levobupivacaineas above + 0.7 mg/kg MgSo4 . The patient, the
      anesthesiologist who administered the drugs, and the data collector will be blinded to the
      study drugs.
    
  